You probably didn't see it coming, but you are not alone in your diagnosis. Below are helpful resources to guide your path to survivorship as a patient under age 50.
The incidence rate of colorectal cancer is rising by about two percent annually in people under age 50.
Learn more here about young-onset risks, treatment, and support.
As a young-onset colorectal cancer patient, you will face unique challenges. Use these resources to help guide you on your path to survivorship.
Get started by learning the basics about colorectal cancer.
You're never too young for colorectal cancer. Learn more about young- onset colorectal cancer and ways to educate yourself about the risks of this disease.
Our Never Too Young (N2Y) Program, with the support of a dedicated Taskforce, is changing how the world sees this disease. Together, we’re increasing awareness, building a community, and learning more about young-onset colorectal cancer.
From online group chat and our private Facebook page to financial assistance and navigators –we have a the right kind of support for everyone who needs it.
Our Helpline is free and available to support you. Helpline staff members are certified patient and family support navigators who have walked in your shoes and are ready to listen and answer any questions.
Finding a clinical trial can be intimidating, but we are here to help you explore your options and help you prepare a list of trials to take to your doctor.
Discover how Hope overcame stage IV colorectal cancer with an innovative HAI liver pump, staying active and proving that second chances are possible.
Allies shared their stories and the vital need to end colorectal cancer in this video presented at the national Blue Hope Bash in November 2024. The video features Bash co-chair and patient Alison Friedman.
The U.S. Food and Drug Administration has approved sotorasib in combination with panitumumab for the treatment of adult patients with KRAS G12C-mutated metastatic colorectal cancer.